Opioid Use Disorder __________________________________________________________________________ MDRI10OD — 10 CREDIT HOURS R elease D ate : 04/01/24 E xpiration D ate : 03/31/27
Opioid Use Disorder
In addition to receiving AMA PRA Category 1 Credit TM , physicians participating in Maintenance of Certification will receive the following points appropriate to their certifying board: 10 ABIM MOC Points, 10 ABS MOC Points, 10 ABPath CC Points.
7. List the issues associated with the abuse of or dependence on legitimately prescribed opioids. 8. Discuss the role of crisis intervention and harm reduction in the management of opioid abuse and dependence. 9. Identify methods of managing the detoxification and withdrawal associated with cessation of opioid abuse or dependence. 10. Discuss therapies used to maintain extended abstinence from opioids, including agonist replacement and abstinence therapies. 11. Identify common psychologic comorbidities present in opioid-dependent patients and implications for treatment. 12. Outline the effects of opioid use on fetuses and neonates and appropriate interventions for opioid- dependent pregnant women. 13. Identify factors associated with favorable/unfavorable treatment outcome. Faculty Mark Rose, BS, MA, LP , is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addiction research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer- reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations.
HOW TO RECEIVE CREDIT
• Read the enclosed course. • Complete the final examination questions at the end. A score of 70% is required. • Return your customer information/answer sheet, evaluation, and payment to InforMed by mail or complete online at BOOK.CME.EDU.
Audience This course is designed for medical and mental healthcare providers, including physicians, nurses, pharmacy professionals, social workers, and counselors/therapists who may be involved in identifying or treating opioid use disorder. Course Objective The purpose of this course is to provide healthcare professionals with current information on frontotemporal dementia (FTD). Understanding the epidemiology, pathology, clinical features, diagnostic process, genetics, symptom treatment/management, role of brain autopsy, and current research provides a foundation for the care of patients with FTD and support for their families. Learning Objectives Upon completion of this course, you should be able to: 1. Define key terms associated with opioid abuse and dependence. 2. Outline the background and epidemiology of opioid use and abuse, including risk factors for misuse and dependence. 3. Describe the pharmacology and clinical effects of opioids. 4. Discuss characteristics of specific opioid drugs and opioid antagonists. 5. Review the natural history, pathophysiology, and effects of opioid abuse and dependence. 6. Identify signs and symptoms of opioid overdose and withdrawal.
Mention of commercial products does not indicate endorsement.
14
MDRI2026
Powered by FlippingBook